ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 675967 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 675967; 2) Community: the network communities that were significantly associated with the response to NSC 675967; 3) Molecule: the relationships between components within communities and NSC 675967; 4) MDR: the compounds that were significantly associated with the NSC 675967.

NSC Compound Enrichment Correlation
NSC 133118 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) 0.0430505868034761 0.084415824
NSC 144163 Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- 0.0430505868034761 0.32706896
NSC 256926 HYRCANOSIDE 0.0430505868034761 0.16721251
NSC 270057 Hydroxypristimerin 0.0430505868034761 0.39478674
NSC 287069 Epicorazine A 0.0430505868034761 0.54810746
NSC 295426 Propanoic acid, 2-methyl-, 2,3,3a,4,5,8,9,11a-octahydro-6,10-bis(hydroxymethyl)-3-methylene-2-oxocyclodeca[b]furan-4-yl ester, [3aR-(3aR*,4S*,6Z,10Z,11aR*)]- (9CI) 0.0430505868034761 0.17888128
NSC 359415 Null 0.0430505868034761 0.34244042
NSC 37432 2-Propen-1-one, 3-(2-hydroxyphenyl)-1-phenyl- (9CI) 0.0430505868034761 0.43072917
NSC 601679 Null 0.0430505868034761 0.307379
NSC 603084 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (E)- 0.0430505868034761 0.43060666
Total:135  Current:118    [First] [Prev] [Next] [Last]